Source: Investing.com ↗

H.C. Wainwright reiterates Immunic stock rating on MS drug progress

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,201.37

+0.82%

ETH/USDT

$2,743.98

+0.42%

ZEC/USDT

$1,620.55

+6.72%

XRP/USDT

$1.61

+5.79%